Global Biotech Industry

The global biotech industry, led by the United States, was $84.6 billion in 2010 and is expected to grow at a 7% CAGR to $103 billion by 2013, as a result of the following primary drivers

• Active participation by private players.
• Rising information technology innovation
• Improving healthcare infrastructure worldwide.

Despite the recent economic downturn, there was only a 10% decrease in the number of biotechnology companies worldwide through September 2010 from the year prior, a modest decline largely attributed to the stimulus of the United States though Europe and Asia are fast growing international markets

Several European biotechnology companies have announced plans through collaborations with international partners, increasing production efficiencies and adding corporate earnings growth.

Global Biotech Industry Distribution by Geography
 

The Asia-Pacific biotech market is projected to grow at a CAGR of 16% between 2010 and 2012